Monsanto the disposition of product lines unrelated to agriculture. In 1985, Monsanto acquired G. D. Searle & Company, a life sciences company that focused on pharmaceuticals, agriculture and animal health. In 1993, its Searle division filed a patent application for Celebrex, which in 1998 became the first selective COX‑2 inhibitor to be approved by the U.S. Food and Drug Administration (FDA). Celebrex became a blockbuster drug and was often mentioned as a key reason for Pfizer's acquisition of Monsanto's pharmaceutical business in 2002. In 1994, Monsanto introduced a recombinant version of bovine somatotropin, brand-named Posilac. Monsanto later sold this business to
G.D.R. Monsanto G.D.R. Monsanto G.D.R. Monsanto is a Portuguese football club based in the village of Monsanto in the municipality of Idanha-a-Nova in east Portugal. They currently play in one of eight regional leagues in the Portuguese Third Division in the fourth tier of Portuguese football. G.D.R. Monsanto has existed informally for most of the 20th century, but was formally constituted in 1976 as part of a sports club that also competes in cycling and chess. In recent years, the team played in the Santarém District Leagues before reaching promotion to the Portuguese Third Division in 2004 and subsequently the Portuguese Second